Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | MOMA-313 |
Synonyms | |
Therapy Description |
Limited information is currently available on MOMA-313, a putative polymerase theta helicase inhibitor (Aug 2024). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
MOMA-313 | MOMA 313|MOMA313 | Limited information is currently available on MOMA-313, a putative polymerase theta helicase inhibitor (Aug 2024). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT06545942 | Phase I | MOMA-313 + Olaparib MOMA-313 | Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors | Recruiting | USA | 0 |